François Morin

François Morin

Auto-generated profile, based on publicly available information

François Morin

Department of Emergency Medicine, University Hospital of Angers, Angers, France

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2001 in Journal of Vacuum Science & Technology A
Verified
Journal Article
Open access
PDP. Decorse
P. Decorse
EQE. Quenneville
E. Quenneville
SPS. Poulin
S. Poulin
MMMichel Meunier
Michel Meunier
AYArthur Yelon
Arthur Yelon
FMF. Morin
F. Morin
La 0.5 Sr 0.5 MnO 3 thin films were deposited onto sapphire substrates by means of the pulsed-laser deposition technique. These films were characterized by several techniques including x-ray diffraction, Rutherford backscattering spectrometry, energy-dispersive x-ray, atomic-force microscopy, scanning electron microscopy, and x-ray photoelectron spectroscopy (XPS). The cation ratios are the same in the deposited films as in the target. However, strontium segregation occurs at the film surface with an enrichment in this element compared to Mn and La, as shown by XPS. In addition, a clear correlation between the three different contributions which compose the O(1s) XPS signal and the Sr, La, and Mn surface concentrations has been established. Annealing the films at a sufficiently high-temperature produces the same crystal structure as in the target.

2 March 2021 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
GCGuillaume Carteaux
Guillaume Carteaux
MPManuella Pons
Manuella Pons
FMFrançois Morin
François Morin
STSamuel Tuffet
Samuel Tuffet
ALArnaud Lesimple
Arnaud Lesimple
ADArmand Mekontso Dessap
Armand Mekontso Dessap
Background: We describe a frugal approach (focusing on needs, performance, and costs) to manage a massive influx of COVID-19 patients with acute hypoxemic respiratory failure (AHRF) using the Boussignac valve protected by a filter (“Filter Frugal CPAP”, FF-CPAP) in and out the ICU. Methods: (1) A bench study measured the impact of two filters with different mechanical properties on CPAP performances, and pressures were also measured in patients. (2) Non-ICU healthcare staff working in COVID-19 intermediate care units were trained with a video tutorial posted on a massive open online course. (3) A clinical study assessed the feasibility and safety of using FF-CPAP to maintain oxygenation and manage patients out of the ICU during a massive outbreak. Results: Bench assessments showed that adding a filter did not affect the effective pressure delivered to the patient. The resistive load induced by the filter variably increased the simulated patient’s work of breathing (6–34%) needed to sustain the tidal volume, depending on the filter’s resistance, respiratory mechanics and basal inspiratory effort. In patients, FF-CPAP achieved pressures similar to those obtained on the bench. The massive training tool provided precious information on the use of Boussignac FF-CPAP on COVID-19 patients. Then 85 COVID-19 patients with ICU admission criteria over a 1-month period were studied upon FF-CPAP initiation for AHRF. FF-CPAP significantly decreased respiratory rate and increased SpO 2 . Thirty-six (43%) patients presented with respiratory indications for intubation prior to FF-CPAP initiation, and 13 (36%) of them improved without intubation. Overall, 31 patients (36%) improved with FF-CPAP alone and 17 patients (20%) did not require ICU admission. Patients with a respiratory rate > 32 breaths/min upon FF-CPAP initiation had a higher cumulative probability of intubation ( p < 0.001 by log-rank test). Conclusion: Adding a filter to the Boussignac valve does not affect the delivered pressure but may variably increase the resistive load depending on the filter used. Clinical assessment suggests that FF-CPAP is a frugal solution to provide a ventilatory support and improve oxygenation to numerous patients suffering from AHRF in the context of a massive outbreak.

23 August 2021 in Emergency Medicine Journal
Verified
Journal Article
Closed access
PDF file
DDDelphine Douillet
Delphine Douillet
TSThomas Saloux
Thomas Saloux
PRPauline Ravon
Pauline Ravon
FMFrançois Morin
François Morin
TMThomas Moumneh
Thomas Moumneh
DSDominique Savary
Dominique Savary
Background The aim was to describe the organisational changes in French EDs in response to the COVID-19 pandemic with regard to architectural constraints and compare with the recommendations of the various bodies concerning the structural adjustments to be made in this context. Methods As part of this cross-sectional study, all heads of emergency services or their deputies were contacted to complete an electronic survey. This was a standardised online questionnaire consisting of four parts: characteristics of the responding centre, creation of the COVID-19 zone and activation of the hospital’s emergency operations plan, flow and circulation of patients and, finally, staff management. Each centre was classified according to its workload related to COVID-19 and its size (university hospital centre, high-capacity hospital centre and low-capacity hospital centre). The main endpoint was the frequency of implementation of international guidelines for ED organisation. Results Between 11 May and 20 June 2020, 57 French EDs completed the online questionnaire and were included in the analysis. Twenty-eight EDs were able to separate patient flows into two zones: high and low viral density (n=28/57, 49.1%). Of the centres included, 52.6% set up a specific triage area for patients with suspected COVID-19 (n=30/57). Whereas, in 15 of the EDs (26.3%), the architecture made it impossible to increase the surface area of the ED. Conclusion All EDs have adapted, but many of the changes recommended for the organisation of ED could not be implemented. ED architecture constrains adaptive capacities in the context of COVID-19.

17 May 2022 in Resuscitation
Verified
Journal Article
Closed access
FMFrançois Morin
François Morin
DDDelphine Douillet
Delphine Douillet
LLLionel Lamhaut
Lionel Lamhaut
MFMarc Fadel
Marc Fadel
DSDominique Savary
Dominique Savary

1 November 2007 in Nouvelles FondationS
Verified
Journal Article
Closed access
PDF file
FMFrançois Morin
François Morin

10 February 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
FMFrançois Morin
François Morin
DDDelphine Douillet
Delphine Douillet
JHJean-Francois Hamel
Jean-Francois Hamel
JRJosué Rakotonjanahary
Josué Rakotonjanahary
FDFlorence Dupriez
Florence Dupriez
PRPierre Marie Roy
Pierre Marie Roy
Introduction In the context of the COVID-19 pandemic, early identification of patients who are likely to get worse is a major concern. Severity mainly depends on the development of acute respiratory distress syndrome (ARDS) with a predominance of subpleural lesions. Lung point-of-care ultrasonography (L-POCUS) is highly effective in detecting pulmonary peripheral patterns and may be appropriate for examining patients with COVID-19. We suggest that L-POCUS performed during the initial examination may identify patients with COVID-19 who are at a high risk of complicated treatment or unfavourable evolution. Methods and analysis Point-of-care ultrasonography for risk stratification of non-critical COVID-19 patients on admission is a prospective, multicentre study. Adult patients visiting the emergency department (ED) of participating centres for suspected or confirmed COVID-19 are assessed for inclusion. Included patients have L-POCUS performed within 48 hours following ED admission. The severity of lung damage is assessed using the L-POCUS score based on 36 points for ARDS. Apart from the L-POCUS score assessment, patients are treated as recommended by the WHO. For hospitalised patients, a second L-POCUS is performed at day 5±3. A follow-up is carried out on day 14, and the patient’s status according to the Ordinal Scale for Clinical Improvement for COVID-19 from the WHO is recorded. The primary outcome is the rate of patients requiring intubation or who are dead from any cause during the 14 days following inclusion. We will determine the area under the ROC curve of L-POCUS. Ethics and dissemination The protocol has been approved by the French and Belgian Ethics Committees and is carried out in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The study is funding by a grant from the French Health Ministry, and its findings will be disseminated in peer-reviewed journals and at scientific conferences. Trial registration number NCT04338100.